TITLE
A DEVICE FOR THE ADMINISTRATION OF HOMEPATHIC COMPOSITIONS FIELD OF THE INVENTION
The present invention relates to a device for the
administration of homeopathic compositions. The present invention also relates to a method of manufacturing a device for the administration of homeopathic compositions and methods for treatment of injury or illness by use of the device of the present invention.
BACKGROUND OF THE INVENTION
The use of homeopathic preparations based on herbal or vegetable extracts is well known. The preparations produced are administered in a variety of ways including oral, topical and injectable forms. The method of delivery of the preparation may have a significant effect on the efficacy of the preparation in producing the desired effect.
Topical methods involving applying remedies to the surface of the skin are favoured in some respects because of the non-invasive nature of the treatment and the fact that the skin is not punctured. However, traditional methods of topical administration have suffered from the disadvantage of being slow acting and undesirable for use where the patient is suffering acute pain.
Acupuncture involving the stimulation of certain specific sites on the body is also a well known method of treatment. The treatment typically involves the insertion of needles into the skin at certain specific sites. The selection of
the site used is related to the symptoms being addressed by the treatment. Many of the drawbacks of traditional acupuncture methods stem from the need to puncture the skin during the treatment.
Thus, a method of delivering a homeopathic composition which is non invasive and fast acting is desirable.
Moreover, the treatment of symptoms by a method which involves acupuncture pressure points without the need to break the surface of the skin is also desirable.
SUMMARY OF THE INVENTION
The present invention seeks to address the problems of the prior art by providing a device for the administration of homeopathic compositions which enables the composition to be delivered in a non invasive manner whilst providing comparable speed of action to injectable or other invasive delivery methods.
According to a first aspect of the present invention there is provided a device for the administration of homeopathic compositions comprising a fibre optic material treated with a homeopathic composition.
According to a further aspect of the present invention there is provided a method of manufacturing a device for the administration of homeopathic compositions comprising immersing a length of fibre optic material in a homeopathic composition, allowing the fibre optic to remain in the composition for a period of time subsequently dividing the fibre optic into portions for use.
According to a still further aspect of the present
invention there is provided a method of treatment
comprising applying a fibre optic material treated with a
homeopathic composition to an acupuncture point in a body. The device of the present invention is used primarily to ameliorate pain occurring as a result of spinal
malfunction, and/or dura membrane stress, or through the body lymphatic drainage system or cranial malfunction.
The fibre optic material is preferably as prepared as a disc formed by slicing transversely through a length of the fibre optic material in which has previously been treated with the homeopathic composition. The fibre optic material is preferably a polymer fibre optic material. The
homeopathic composition is preferably an extract of vegetable such as brussell sprout, zucchini or chestnuts. The homeopathic composition is formed by milling the vegetable and immersing the milled vegetable in an
extraction solvent for a period of time and eventually separating the liquid extract.
Mixtures of ethanol and water are the preferred extraction solvent mixture.
The liquid extract thus formed is diluted in a mixture of dilution solvents to form a first dilution (IX). The first dilution IX is then diluted further by serial dilution to form a second dilution 2X. The process of dilution may be continued until the thirtieth dilution 30X has been made. Further dilutions beyond 30X may also be made. Each dilution IX to 30X and beyond may be used as a homeopathic composition.
A length of the fibre optic material is immersed in a specified dilution for a period of time. The duration of immersion is determined by the level of potency of the final product which is desired. As the duration of the
immersion increases, the level of potency of the final product increases correspondingly. Following the immersion in the extract, the activated fibre optic material is dried.
An alternative method of treating the fibre optic material with the homeopathic composition is to use what is known as potency transfer machine. A potency transfer machine is an electronic device that has an "in" chamber and an "out" chamber and is operational at 9 volts.
The substances to be transferred are placed in the "in" chamber and the substances to be transferred to are placed in the "out" chamber. After setting the machine at the required setting, substances in the "in" chamber are
transferred electrically to the substances in the "out" chamber. Typically, the homeopathic composition is placed in the "in" chamber and the fibre optic material in the "out" chamber. This produces an electrical resonance in the fibre optic.
Whilst not wishing to be bound by any theory, it is
suggested that this resonance is active in achieving the desired relief of symptoms in a patient to whom the device of the present invention is administered.
This type of homeopathic transfer is used by homeopaths mainly when manufacturing a specific preparation for
individual patients. However, the equipment may be adapted to suit large scale production.
The potency transfer machine operates from mains power and has a transformer to reduce the electrical power to the power required. The potency transfer machine has specific
advantages over the manual method of insertion in as much as it is more accurate and therefor allows greater
consistency in production, it is faster therefor allowing greater productivity and it can be computer controlled. The activated fibre optic material is sliced transversely to the longitudinal axis of the fibre optic to form discs. The discs are typically about 0.2mm to 0.6mm in thickness and 2-5mm in diameter. The discs of activated fibre optic are placed on one or more known acupuncture points on a body. The location of the acupuncture points effective for treatment of various conditions would be known to those skilled in the art. Typical acupuncture points in the treatment of pain results from spinal malfunction or spinal stress are those known as pericardium 5 (Pc5) and Triple Warmer 8 (TW8), both of which are located on the lower forearm.
The fibre optic discs are applied to the body on the selected pressure points for up to 12 hours. The polymer discs may conveniently be attached to the body by the use of small adhesive strips such as commercially available sticking plasters.
Accordingly, the device of the present invention may be produced by carrying out successively the steps of
a) processing the vegetable to form the vegetable extract; b) taking the vegetable extract from step a) and forming the diluted extracts;
c) processing the fibre optic in the diluted extract from step b) either directly or via a potency transfer machine; and
d) applying the fibre optic to the selected pressure point.
Each of the above described steps and will now be described in detail.
a) Extract
The vegetables are sliced or chopped sufficiently thinly to enable them to be fed through a series of rollers which mill and crush the vegetable.
The milled vegetable is added to an extraction solvent, preferably ethanol. The ratio of milled vegetable to extraction solvent may vary from one kilogram of vegetable to one litre of extraction solvent, to one kilogram of vegetable to five litres of extraction solvent. Typically, the extracts of the present invention are formed from one kilogram of vegetable to two litres of extraction solvent. The solvent used to form the liquid extract is preferably a mixture of water and ethanol. The volume ratio of water to ethanol may be varied in the ratio from 9:1 to 1:9.
The mixture of milled vegetable and extraction solvent is allowed to stand for a period of between 6-10 days.
Following the standing period, the extraction
solvent/extract mixture is decanted from the vegetable solids and the vegetable solids are dried.
The extraction solvent/extract mixture obtained from the above process may then be passed over the dried vegetable matter by placing the dried vegetable matter into a filter and percolating the solvent and extract mixture through the filter. This process is conducted at room temperature.
The liquid produced from the percolation is the vegetable
extract.
As an alternative to the percolation process, the dried vegetable matter may be burnt to produce charred material and the solvent and extract mixture filtered through the charred material to produce the vegetable extract,
b). Dilution of Extract.
One part of the vegetable extract formed in step a) is combined with 9 parts of a dilution solvent to form the first dilution IX.
The dilution solvent used to form the first dilution is preferably a mixture of water and ethanol. The dilution solvent may contain up to 40% by volume ethanol. The ethanol content of the dilution solvent is preferably maintained at a sufficient level to prevent any
fermentation occurring in the extract. The preferred volume mixture for the dilution solvent is 10% ethanol in 90% water.
The same composition of dilution solvent used to form the first dilution is used to form all subsequent dilutions. The second dilution 2X is formed by taking one part of the first dilution IX and combining this with 9 parts of the dilution solvent.
Similarly, the third dilution 3X is formed by taking 1 part of the second dilution and combining this with 9 parts of the dilution solvent.
The dilution procedure may be continued to form a fourth dilution 4X from the third dilution as described above. Fifth and other subsequent dilutions may be formed.
Typically, the product of the present invention uses
dilutions between the sixth dilution, 6X, and the thirtieth dilution, 30X.
c) processing fibre optic in diluted extract.
The fibre optic material used in the present invention is preferably a polymer fibre optic material. Conventional glass fibre optic may be used but produces a risk of slivers of glass becoming embedded in the skin of a patient which may be harmful.
The fibre optic used in the present invention is preferably optically clear and is coated in a fluorinated hydrocarbon coating.
The polymer fibre optic is preferably between 2mm and 5mm in diameter. The preferred diameter of the fibre optic is 3mm.
The fibre optic is preferably detoxified before use by passing a voltage of 9v across the fibre for 10 to 15 minutes, according to the length of the fibre.
The fibre optic may then be processed directly as follows. A length of fibre optic, preferably detoxified, is then immersed in a selected dilution of the extract. For
example, a length of fibre of 3mm diameter may be immersed in the sixth dilution 6X. The period of immersion required is dependent of the level of activity required in the final product. The greater the duration of the immersion the more active the final product. Typically, the fibre optic would be immersed for between 30 minutes and 120 minutes.
Following immersion the treated fibre optic is removed from the dilution and dried.
The treated fibre optic is sliced transversely to a
longitudinal axis of the fibre to produce discs of fibre optic. The discs are between 0.2 to 0.6mm preferably 0.5mm in width.
Alternatively, the fibre optic may be treated in a potency transfer machine. The extracts prepared in step b are placed in a bottle in the "in" chamber of the potency transfer machine and the fibre optic is placed in the "out" chamber of the machine. The machine is set at the correct calibration for the required potency and switched on, the potency is then transferred from the "in" chamber to the "out" chamber and the potency resonance is absorbed into the fibre optic in the "out" chamber. The time for
transfer is between 13 seconds and 2 hours dependent on potency strength required and the amount of fibre optic being processed,
d) Application.
The discs formed in step c are conveniently placed in the centre of small circular sticking plasters. The plasters are attached to the skin surface of the patient such that the treated fibre optic disc is located directly over a selected acupuncture point of the patient in contact with the skin surface.
In the treatment of spinal stress the acupuncture points most commonly used are Pc5 and TW8, although other known acupuncture points may be used.
The effect of the treatment as described above is usually noticeable in the patient between 15 seconds to 2 hours after the application of the treated fibre optic to the skin at the correct acupuncture point.
The treated fibre optic may be maintained in position for up to 12 hours, depending on the strength of the dilution used in the extract. Further, the treatment may be repeated as often as desired.
The present invention as described above thus provides a non-invasive method of acupuncture which does not require the skin to be punctured. Further, the present invention also provides a novel method of delivering known vegetable extract homeopathic compositions to the body through the acupuncture points.
Modifications and variations such as would be apparent to a skilled addressee are deemed within the scope of the present invention.